Author(s): Lalit Kumar1, BS Suhas, Girish Pai K1, Ruchi Verma*
DOI: Not Available
Views:
1134
(pdf),
9478
(html)
Access:
Open Access
Cite: Not Available doi: Not Available
Read More
|
Author(s): Urvi Das Sharma, Lalit Kumar, Ruchi Verma
DOI: 10.52711/0974-360X.2022.00726
Views:
318
(pdf),
8151
(html)
Access:
Open Access
Cite: Urvi Das Sharma, Lalit Kumar, Ruchi Verma. Selection of Stationary Phase and Mobile Phase in High Performance Liquid Chromatography. Research Journal of Pharmacy and Technology. 2022; 15(9):4325-2. doi: 10.52711/0974-360X.2022.00726
Read More
|
Author(s): Lohith T N, Lalit Kumar, Ruchi Verma
DOI: 10.5958/0974-360X.2020.00342.X
Views:
105
(pdf),
3088
(html)
Access:
Open Access
Cite: Lohith T N, Lalit Kumar, Ruchi Verma. Design, Molecular Docking, ADME Analysis and Molecular Dynamics Studies of Novel Acetylated Schiff bases as COX-2 inhibitors. Research J. Pharm. and Tech. 2020; 13(4):1899-1904. doi: 10.5958/0974-360X.2020.00342.X
Read More
|
Author(s): K Poojita, Fajeelath Fathima, Rajdeep Ray, Lalit Kumar, Ruchi Verma
DOI: 10.52711/0974-360X.2021.01093
Views:
16
(pdf),
2736
(html)
Access:
Open Access
Cite: K Poojita, Fajeelath Fathima, Rajdeep Ray, Lalit Kumar, Ruchi Verma. Atom based 3D QSAR and Fingerprint based 2D QSAR of Novel Molecules as MmpL3 receptor inhibitors for Mycobacterium tuberculosis. Research Journal of Pharmacy and Technology. 2021; 14(12):6321-9. doi: 10.52711/0974-360X.2021.01093
Read More
|
Author(s): Lalit Kumar, Ruchi Verma
DOI: 10.5958/0974-360X.2017.00431.0
Views:
31
(pdf),
2641
(html)
Access:
Open Access
Cite: Lalit Kumar, Ruchi Verma. Molecular docking based approach for the design of Novel Flavone Analogues as inhibitor of Beta-Hydroxyacyl-ACP Dehydratase HadAB complex. Research J. Pharm. and Tech. 2017; 10(8): 2439-2445. doi: 10.5958/0974-360X.2017.00431.0
Read More
|
Author(s): Shrusti Rao, Varadaraj Bhat, Fajeelath Fathima, Santosh Kumar, Ruchi Verma
DOI: 10.5958/0974-360X.2020.01012.4
Views:
92
(pdf),
2424
(html)
Access:
Open Access
Cite: Shrusti Rao, Varadaraj Bhat, Fajeelath Fathima, Santosh Kumar, Ruchi Verma. In-silico studies of Novel triazole derivatives as inhibitor of 14α demethylase CYP51. Research J. Pharm. and Tech. 2020; 13(12):5806-5810. doi: 10.5958/0974-360X.2020.01012.4
Read More
|
Author(s): K Poojita, Fajeelath Fathima, Rajdeep Ray, Lalit Kumar, Ruchi Verma
DOI: 10.52711/0974-360X.2021.01026
Views:
42
(pdf),
2347
(html)
Access:
Open Access
Cite: K Poojita, Fajeelath Fathima, Rajdeep Ray, Lalit Kumar, Ruchi Verma. 3D Atom based QSAR model of DprE1 inhibitors as Anti-tubercular Agents. Research Journal of Pharmacy and Technology. 2021; 14(11):5903-0. doi: 10.52711/0974-360X.2021.01026
Read More
|
Author(s): Arpan Adhikary, Ronak Nair, Lakshya Moukthika, Ruchi Verma
DOI: 10.52711/0974-360X.2023.00761
Views:
20
(pdf),
1221
(html)
Access:
Open Access
Cite: Arpan Adhikary, Ronak Nair, Lakshya Moukthika, Ruchi Verma. 2D QSAR and Atom based 3D QSAR study of Tropomyosin Receptor Kinases inhibition by pyrazol derivatives. Research Journal of Pharmacy and Technology 2023; 16(10):4681-0. doi: 10.52711/0974-360X.2023.00761
Read More
|
Author(s): Urvi Das Sharma, Ganesh CH, Ruchi Verma, Lalit Kumar
DOI: 10.52711/0974-360X.2023.00980
Views:
22
(pdf),
1125
(html)
Access:
Open Access
Cite: Urvi Das Sharma, Ganesh CH, Ruchi Verma, Lalit Kumar. HPLC Method Development and Validation for Residue Analysis of Steroid. Research Journal of Pharmacy and Technology.2023; 16(12):6039-4. doi: 10.52711/0974-360X.2023.00980
Read More
|